Trial Profile
SO03-01 - EVALUATION OF THE EFFECT OF N-3 SUPPLEMENTATION ON FUNCTIONAL IMPROVEMENT IN POSTSTROKE PATIENTS
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2014
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Stroke complications; Vascular dementia
- Focus Therapeutic Use
- 26 Feb 2014 New trial record